Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 11 | 463,384 | $12.19M |
| Option exercise | 17 | 833,550 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
38 Form 4 filings on record, the earliest from May 21, 2025, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| David Mountcastle - Officer | Open-market sale | Common Stock, par value $0.01 per share | 21,275 | $27.67 | $589K | |
| David Mountcastle - Officer | Open-market sale | Common Stock, par value $0.01 per share | 600 | $27.57 | $17K | |
| Matthew Shawn Morris - Director | Option exercise | Common Stock, par value $0.01 per share | 59,037 | $2.00 | $118K | |
| Matthew Shawn Morris - Director | Open-market sale | Common Stock, par value $0.01 per share | 59,037 | $27.33 | $1.61M | |
| Matthew Shawn Morris - Director | Option exercise | Common Stock, par value $0.01 per share | 53,722 | $2.00 | $107K | |
| Matthew Shawn Morris - Director | Open-market sale | Common Stock, par value $0.01 per share | 53,722 | $27.24 | $1.46M | |
| Matthew Shawn Morris - Director | Option exercise | Stock Option (Right to Purchase) | 59,037 | $0.00 | - | |
| Matthew Shawn Morris - Director | Option exercise | Stock Option (Right to Purchase) | 53,722 | $0.00 | - | |
| David Mountcastle - Officer | Open-market sale | Common Stock, par value $0.01 per share | 24,734 | $27.50 | $680K | |
| Matthew Shawn Morris - Director | Open-market sale | Common Stock, par value $0.01 per share | 52,823 | $25.72 | $1.36M | |
| Matthew Shawn Morris - Director | Option exercise | Common Stock, par value $0.01 per share | 82,675 | $2.00 | $165K | |
| Matthew Shawn Morris - Director | Open-market sale | Common Stock, par value $0.01 per share | 45,634 | $26.52 | $1.21M | |
| Matthew Shawn Morris - Director | Open-market sale | Common Stock, par value $0.01 per share | 37,041 | $26.93 | $998K | |
| Matthew Shawn Morris - Director | Option exercise | Stock Option (Right to Purchase) | 52,823 | $0.00 | - | |
| Matthew Shawn Morris - Director | Option exercise | Stock Option (Right to Purchase) | 82,675 | $0.00 | - | |
| Matthew Shawn Morris - Director | Option exercise | Common Stock, par value $0.01 per share | 52,823 | $2.00 | $106K | |
| Matthew Shawn Morris - Director | Option exercise | Stock Option (Right to Purchase) | 88,110 | $0.00 | - | |
| Matthew Shawn Morris - Director | Option exercise | Stock Option (Right to Purchase) | 63,212 | $0.00 | - | |
| Matthew Shawn Morris - Director | Option exercise | Common Stock, par value $0.01 per share | 88,110 | $2.00 | $176K | |
| Matthew Shawn Morris - Director | Open-market sale | Common Stock, par value $0.01 per share | 88,110 | $25.33 | $2.23M | |
| Matthew Shawn Morris - Director | Option exercise | Common Stock, par value $0.01 per share | 63,212 | $2.00 | $126K | |
| Matthew Shawn Morris - Director | Open-market sale | Common Stock, par value $0.01 per share | 63,212 | $25.33 | $1.60M | |
| David Mountcastle - Officer | Option exercise | Common Stock, par value $0.01 per share | 17,196 | $2.00 | $34K | |
| David Mountcastle - Officer | Open-market sale | Common Stock, par value $0.01 per share | 17,196 | $25.18 | $433K | |
| David Mountcastle - Officer | Option exercise | Stock Option (Right to Purchase) | 5,962 | $0.00 | - | |
| David Mountcastle - Officer | Option exercise | Stock Option (Right to Purchase) | 1,001 | $0.00 | - | |
| David Mountcastle - Officer | Option exercise | Stock Option (Right to Purchase) | 1,336 | $0.00 | - | |
| David Mountcastle - Officer | Option exercise | Stock Option (Right to Purchase) | 8,897 | $0.00 | - | |
| Grant or award | Common Stock, $0.01 par value per share | 8,463 | $0.00 | - | ||
| Lance Berberian - Director | Grant or award | Common Stock, $0.01 par value per share | 8,463 | $0.00 | - | |
| Nancy G. Cocozza - Director | Grant or award | Common Stock, $0.01 par value per share | 8,463 | $0.00 | - | |
| Pamela O. Kimmet - Director | Grant or award | Common Stock, par value $0.01 per share | 8,463 | $0.00 | - | |
| Thomas A. McCarthy - Director | Grant or award | Common Stock, $0.01 par value per share | 8,463 | $0.00 | - | |
| Matthew Shawn Morris - Director | Grant or award | Common Stock, par value $0.01 per share | 8,463 | $0.00 | - | |
| Jaewon Ryu - Director | Grant or award | Common Stock, $0.01 par value per share | 8,463 | $0.00 | - | |
| David P. King - Director | Grant or award | Common Stock, $0.01 par value per share | 8,463 | $0.00 | - | |
| Parth Mehrotra - Officer | Open-market sale | Common Stock, $0.01 par value per share | 105,439 | $22.55 | $2.38M | |
| Parth Mehrotra - Officer | Open-market sale | Common Stock, $0.01 par value per share | 15,647 | $22.64 | $354K | |
| David Mountcastle - Officer | Open-market sale | Common Stock, par value $0.01 per share | 3,385 | $22.60 | $77K | |
| David Mountcastle - Officer | Option exercise | Common Stock, par value $0.01 per share | 7,179 | $2.00 | $14K | |
| David Mountcastle - Officer | Open-market sale | Common Stock, par value $0.01 per share | 7,179 | $25.03 | $180K | |
| David Mountcastle - Officer | Option exercise | Common Stock, par value $0.01 per share | 1,206 | $2.00 | $2K | |
| David Mountcastle - Officer | Open-market sale | Common Stock, par value $0.01 per share | 1,206 | $25.00 | $30K | |
| David Mountcastle - Officer | Option exercise | Stock Option (Right to Purchase) | 1,297 | $0.00 | - | |
| David Mountcastle - Officer | Option exercise | Stock Option (Right to Purchase) | 541 | $0.00 | - | |
| David Mountcastle - Officer | Option exercise | Stock Option (Right to Purchase) | 3,010 | $0.00 | - | |
| David Mountcastle - Officer | Option exercise | Stock Option (Right to Purchase) | 2,331 | $0.00 | - | |
| David Mountcastle - Officer | Option exercise | Stock Option (Right to Purchase) | 202 | $0.00 | - | |
| David Mountcastle - Officer | Option exercise | Stock Option (Right to Purchase) | 52 | $0.00 | - | |
| David Mountcastle - Officer | Option exercise | Stock Option (Right to Purchase) | 592 | $0.00 | - | |
| David Mountcastle - Officer | Option exercise | Stock Option (Right to Purchase) | 360 | $0.00 | - | |
| Matthew Shawn Morris - Director | Option exercise | Common Stock, par value $0.01 per share | 17,096 | $2.00 | $34K | |
| Matthew Shawn Morris - Director | Open-market sale | Common Stock, par value $0.01 per share | 17,096 | $24.99 | $427K | |
| Matthew Shawn Morris - Director | Option exercise | Common Stock, par value $0.01 per share | 1,017 | $2.00 | $2K | |
| Matthew Shawn Morris - Director | Open-market sale | Common Stock, par value $0.01 per share | 1,017 | $24.96 | $25K | |
| Matthew Shawn Morris - Director | Option exercise | Stock Option (Right to Purchase) | 17,096 | $0.00 | - | |
| Matthew Shawn Morris - Director | Option exercise | Stock Option (Right to Purchase) | 1,017 | $0.00 | - | |
| David Mountcastle - Officer | Open-market sale | Common Stock, par value $0.01 per share | 5,566 | $20.85 | $116K | |
| David Mountcastle - Officer | Open-market sale | Common Stock, par value $0.01 per share | 6,391 | $22.11 | $141K | |
| Parth Mehrotra - Officer | Open-market sale | Common Stock, $0.01 par value per share | 26,509 | $22.11 | $586K | |
| David Mountcastle - Officer | Open-market sale | Common Stock, par value $0.01 per share | 6,453 | $21.90 | $141K | |
| David Mountcastle - Officer | Open-market sale | Common Stock, par value $0.01 per share | 6,565 | $21.52 | $141K | |
| Parth Mehrotra - Officer | Open-market sale | Common Stock, $0.01 par value per share | 26,763 | $21.90 | $586K | |
| Parth Mehrotra - Officer | Open-market sale | Common Stock, $0.01 par value per share | 27,229 | $21.52 | $586K | |
| Parth Mehrotra - Officer | Grant or award | Common Stock, $0.01 par value per share | 141,342 | $0.00 | - | |
| Parth Mehrotra - Officer | Grant or award | Common Stock, $0.01 par value per share | 171,904 | $0.00 | - | |
| Parth Mehrotra - Officer | Open-market sale | Common Stock, $0.01 par value per share | 21,097 | $22.71 | $479K | |
| Grant or award | Common Stock, $0.01 par value per share | 28,268 | $0.00 | - | ||
| David Mountcastle - Officer | Grant or award | Common Stock, par value $0.01 per share | 42,584 | $0.00 | - | |
| David Mountcastle - Officer | Grant or award | Common Stock, par value $0.01 per share | 35,335 | $0.00 | - | |
| Parth Mehrotra - Officer | Open-market sale | Common Stock, $0.01 par value per share | 21,440 | $23.15 | $496K | |
| Parth Mehrotra - Officer | Open-market sale | Common Stock, $0.01 par value per share | 21,915 | $22.84 | $501K | |
| Parth Mehrotra - Officer | Open-market sale | Common Stock, $0.01 par value per share | 18,865 | $22.84 | $431K | |
| Parth Mehrotra - Officer | Open-market sale | Common Stock, $0.01 par value per share | 1,219 | $23.37 | $28K | |
| Open-market sale | Common Stock, $0.01 par value per share | 4,394 | $23.15 | $102K | ||
| Open-market sale | Common Stock, $0.01 par value per share | 4,949 | $22.84 | $113K | ||
| David Mountcastle - Officer | Open-market sale | Common Stock, par value $0.01 per share | 5,177 | $23.15 | $120K | |
| David Mountcastle - Officer | Open-market sale | Common Stock, par value $0.01 per share | 5,829 | $22.84 | $133K |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR |
Privia Health Group, Inc. (PRVA) had 7 insider filings in the last 90 days, with the most recent on 2026-07-13. The full record for PRVA runs to 38 Form 4 filings, the earliest from 2025-05-21. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of PRVA were filed in the last 90 days.
11 insider sales of PRVA were filed in the last 90 days, totaling $12.19M.
This page tracks PRVA Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add PRVA to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.